Invention Grant
- Patent Title: Antibody for binding to interleukin 4 receptor
-
Application No.: US16809411Application Date: 2020-03-04
-
Publication No.: US10774141B2Publication Date: 2020-09-15
- Inventor: Wei Zheng , Wubin Pan , Xin Yang , Yang Chen , Limin Zhang , Jie Jiang
- Applicant: SUZHOU CONNECT BIOPHARMACEUTICALS, LTD
- Applicant Address: CN Taicang, Jiangsu
- Assignee: Suzhou Connect Biopharmaceuticals, Ltd.
- Current Assignee: Suzhou Connect Biopharmaceuticals, Ltd.
- Current Assignee Address: CN Taicang, Jiangsu
- Agency: Goodwin Procter LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@8daab17
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; C12N5/12 ; C12N15/62 ; C07K16/24 ; A61P37/08 ; A61P29/00 ; C12N15/85 ; A61K38/00 ; A61K45/06

Abstract:
Disclosed is an antibody capable of binding to the interleukin 4 (IL-4) receptor (IL-4). Also disclosed are a nucleic acid sequence encoding the antibody, a vector including the nucleic acid sequence, and a host cell transformed or transfected with the vector. Provided are a method for producing the antibody, a medical use of the antibody, and a kit including the antibody.
Public/Granted literature
- US20200255514A1 ANTIBODY FOR BINDING TO INTERLEUKIN 4 RECEPTOR Public/Granted day:2020-08-13
Information query